Related Experiment Video
Updated: Jun 17, 2025
06:35
Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 24, 2010
16.8K
Standardized statistical framework for comparison of biomarkers: Techniques from ADNI
Danielle J Harvey1, Duygu Tosun2,3, Clifford R Jack4
1Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, USA.
Summary
Biomarkers for Alzheimer's disease trials, like ventricular and hippocampal volume, show high precision. This framework aids in selecting the most effective imaging biomarkers for mild cognitive impairment and dementia research.
Area of Science:
- Neuroimaging
- Biomarker Discovery
- Clinical Trials
Background:
- Biomarkers are crucial for improving clinical trial efficiency and drug discovery.
- Key biomarker attributes include precision and clinical validity.
- Standardized evaluation methods are needed for biomarker comparison.
Purpose of the Study:
- To propose measures for operationalizing biomarker precision and clinical validity.
- To describe a general approach for inference-based comparisons of biomarker performance.
- To apply these methods to structural MRI data in Alzheimer's Disease Neuroimaging Initiative.
Main Methods:
- Development of a general approach for comparing biomarker performance.
- Application of methods to structural MRI data.
- Analysis of data from individuals with mild cognitive impairment (MCI) and mild dementia.
Main Results:
- Ventricular and hippocampal volumes demonstrated the highest precision in detecting longitudinal changes in both MCI and dementia groups.
- Clinical validity varied between the groups, with imaging measures showing differential performance.
- The proposed framework allows for standardized comparison across different imaging modalities and analytical methods.
Conclusions:
- The presented methodology offers a standardized framework for comparing biomarkers.
- Precision in change detection and clinical validity are key criteria for biomarker evaluation.
- Ventricular volume exhibits high precision for both MCI and dementia trials.
- Clinical validity of imaging biomarkers differs more significantly in dementia than in MCI.
Related Concept Videos
01:16Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data
117
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
117
01:12Statistical Software for Data Analysis and Clinical Trials
525
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
525